Breast cancer: an up‐to‐date review and future perspectives

R Hong, B Xu - Cancer communications, 2022 - Wiley Online Library
Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …

Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers

I Larionova, G Tuguzbaeva, A Ponomaryova… - Frontiers in …, 2020 - frontiersin.org
Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to
50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate …

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

S Loibl, F André, T Bachelot, CH Barrios… - Annals of …, 2024 - annalsofoncology.org
Global estimates indicated 2.3 million new cases of breast cancer in 2020, contributing to
nearly 12% of all new cancer cases, with 685 000 deaths in the same year. 1 Breast cancer …

Global, regional, and national lifetime risks of develo** and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of …

S Wang, R Zheng, J Li, H Zeng, L Li, R Chen… - The Lancet …, 2024 - thelancet.com
Background Gastrointestinal cancers account for a quarter of the global cancer incidence
and a third of cancer-related deaths. We sought to estimate the lifetime risks of develo** …

[HTML][HTML] Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

G Argilés, J Tabernero, R Labianca, D Hochhauser… - Annals of …, 2020 - Elsevier
Colorectal cancer (CRC) is the third most common tumour in men and the second in women,
accounting for 10% of all tumour types worldwide. Incidence is 25% higher in males and …

Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study

E Heer, A Harper, N Escandor, H Sung… - The Lancet Global …, 2020 - thelancet.com
Background Breast cancer has distinct causes, prognoses, and outcomes and effects in
patients at premenopausal and postmenopausal ages. We sought to assess the global …

[HTML][HTML] Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca… - Annals of oncology, 2019 - Elsevier
This ESMO Clinical Practice Guidelines provide updated state-of-the-art recommendations
on management of early breast cancer (diagnosis, treatment and follow-up), compiled by a …

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled …

S Qin, Q Li, S Gu, X Chen, L Lin, Z Wang… - The lancet …, 2021 - thelancet.com
Background Inhibition of vascular endothelial growth factor receptor (VEGFR) has shown
antitumour activity in advanced hepatocellular carcinoma, but few studies of VEGFR …

Medical imaging and nuclear medicine: a Lancet Oncology Commission

H Hricak, M Abdel-Wahab, R Atun, MM Lette… - The Lancet …, 2021 - thelancet.com
The diagnosis and treatment of patients with cancer requires access to imaging to ensure
accurate management decisions and optimal outcomes. Our global assessment of imaging …

[PDF][PDF] 2015 年**恶性肿瘤流行情况分析

郑荣寿, 孙可欣, 张思维, 曾红梅, 邹小农, 陈茹… - 中华肿瘤 …, 2019 - researchgate.net
目的汇总分析各省肿瘤登记处上报的2015 年恶性肿瘤登记数据, 估算全国2015
年恶性肿瘤流行情况. 方法收集整理各省501 个登记处上报的2015 年肿瘤登记数据 …